FR2724935B1 - Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique - Google Patents

Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique

Info

Publication number
FR2724935B1
FR2724935B1 FR9411512A FR9411512A FR2724935B1 FR 2724935 B1 FR2724935 B1 FR 2724935B1 FR 9411512 A FR9411512 A FR 9411512A FR 9411512 A FR9411512 A FR 9411512A FR 2724935 B1 FR2724935 B1 FR 2724935B1
Authority
FR
France
Prior art keywords
therapeutics
preparation
compositions containing
nanoparticle compositions
containing nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9411512A
Other languages
English (en)
Other versions
FR2724935A1 (fr
Inventor
Claude Helene
Behmoaras Ester Saison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9411512A priority Critical patent/FR2724935B1/fr
Publication of FR2724935A1 publication Critical patent/FR2724935A1/fr
Application granted granted Critical
Publication of FR2724935B1 publication Critical patent/FR2724935B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9411512A 1994-09-27 1994-09-27 Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique Expired - Lifetime FR2724935B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9411512A FR2724935B1 (fr) 1994-09-27 1994-09-27 Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411512A FR2724935B1 (fr) 1994-09-27 1994-09-27 Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique

Publications (2)

Publication Number Publication Date
FR2724935A1 FR2724935A1 (fr) 1996-03-29
FR2724935B1 true FR2724935B1 (fr) 1996-12-20

Family

ID=9467311

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9411512A Expired - Lifetime FR2724935B1 (fr) 1994-09-27 1994-09-27 Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique

Country Status (1)

Country Link
FR (1) FR2724935B1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT994726E (pt) * 1996-07-10 2002-09-30 West Pharm Serv Drug Res Ltd Composicoes adequadas para entrega de genes a celulas epiteliais
CA2269444A1 (fr) * 1996-10-23 1998-04-30 Skw Trostberg Aktiengesellschaft Procede de production de conjugues biologiquement actifs d'acides nucleiques et de nanoparticules polymeres
EP0860167A1 (fr) * 1997-01-30 1998-08-26 Robert Gurny Agents actifs dérivés de l'ADN et de l'ARN inclus dans des nanoparticules
FR2766092B1 (fr) 1997-07-16 1999-10-08 Centre Nat Rech Scient Dispositif implantable recouvert d'un polymere capable de liberer des substances biologiquement actives
GB9904627D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Polymer compositions for polynucleotide delivery
FR2816949B1 (fr) * 2000-11-17 2003-11-28 Centre Nat Rech Scient Copolymere a structure sequencee compose d'un segment saccharidique lie a au moins un segment hydrophobe bioerodable, et particules correspondantes
FR2841137B1 (fr) 2002-06-20 2004-08-13 Bioalliance Pharma Systeme de vectorisation comprenant des nanoparticules de taille homogene d'au moins un polymere et d'au moins un polysaccharide charge positivement
BRPI0912489B8 (pt) * 2009-12-30 2019-08-20 Univ Minas Gerais conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186072T1 (de) * 1991-06-14 1999-11-15 Isis Pharmaceuticals Inc Antisense-oligonukleotid-inhibition des ras-gen

Also Published As

Publication number Publication date
FR2724935A1 (fr) 1996-03-29

Similar Documents

Publication Publication Date Title
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
MA21129A1 (fr) Un agent modificateur d'impact dans l'emploi des articles fumants
MA26685A1 (fr) Derives d'azetidine leur preparation et les medicaments les contenant
DZ3411A1 (fr) Melanges de polysaccharides derives d'heparine,leur preparation et les compositions pharmaceutiques les contenant
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
FR2607505B1 (fr) Nouveaux derives de piperazinyl-1 pyrimidine, leur preparation et leur application en therapeutique et cosmetique
FR2774687B1 (fr) Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
FR2606410B1 (fr) Imidazopyridines, leur preparation et leur application en therapeutique
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2553777B1 (fr) Nouveaux complexes de platine et leur application en therapeutique
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2724935B1 (fr) Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2796380B3 (fr) Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2796070B1 (fr) Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
ITMI912261A1 (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
IT9020072A0 (it) Cellule umane per l'elevata espressione di geni inseriti in dna ricombinanti episomiali,loro preparazione e loro impiego
FR2805259B1 (fr) Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2669631B1 (fr) Nouveaux derives de l'oxazolidine, leur preparation et leur emploi.
FR2796382B1 (fr) Organopolysiloxanes modifies, leur preparation, et compositions en contenant
FR2542744B2 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
FR2644458B1 (fr) Nouveaux complexes derives du platine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2677355B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.